Can Macrobid (nitrofurantoin) be used in a pregnant woman during the first trimester for a urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin (Macrobid) Use in First Trimester Pregnancy for UTI

Yes, nitrofurantoin can be used in the first trimester of pregnancy for urinary tract infections and is recommended as a first-line agent by European Urology guidelines, though it should be reserved for situations where other suitable alternatives are not available. 1, 2

First-Line Treatment Recommendations

  • Nitrofurantoin (50-100 mg four times daily for 7 days) is the preferred first-line antibiotic for UTIs during the first trimester according to European Urology guidelines. 1

  • Fosfomycin trometamol (3g single dose) is an acceptable alternative to nitrofurantoin for first trimester UTIs. 1

  • Cephalosporins (such as cephalexin 500 mg four times daily) are appropriate alternatives and achieve adequate blood and urinary concentrations with excellent safety profiles. 1

Critical Treatment Context

  • Prompt treatment is essential: untreated bacteriuria increases pyelonephritis risk 20-30 fold (from 1-4% with treatment to 20-35% without treatment). 1, 3

  • Treatment reduces premature delivery and low birth weight infants in pregnant women with UTIs. 3

  • Even asymptomatic bacteriuria must be treated during pregnancy due to significant risk of progression to pyelonephritis and adverse pregnancy outcomes. 1

Important Caveats and Contraindications

  • Nitrofurantoin should NOT be used for suspected pyelonephritis as it does not achieve therapeutic concentrations in the bloodstream. 1, 2

  • Avoid nitrofurantoin after 36 weeks gestation and during labor due to risk of hemolytic anemia in newborns with immature enzyme systems. 2

  • While a 2011 ACOG committee opinion raised concerns about potential birth defects (anencephaly, heart defects, orofacial clefts) with first trimester use, the European guidelines continue to recommend it as first-line therapy. 4

  • Rare but serious pulmonary toxicity can occur, presenting with fever, chills, cough, pleuritic chest pain, and dyspnea—discontinue immediately if these symptoms develop. 5

Antibiotics to Avoid in First Trimester

  • Trimethoprim-sulfamethoxazole should be avoided in the first trimester due to potential teratogenic effects. 1

  • Fluoroquinolones (such as ciprofloxacin) must be avoided throughout pregnancy due to potential adverse effects on fetal cartilage development. 1

Essential Management Steps

  • Always obtain urine culture before initiating treatment to guide antibiotic selection. 1

  • Treatment duration should be 7-14 days to ensure complete eradication of infection. 1, 2

  • Follow-up urine culture 1-2 weeks after completing treatment is recommended to confirm cure. 1

  • Continue periodic screening with urine cultures throughout pregnancy after any treated episode, as recurrence is common. 3

Clinical Algorithm for First Trimester UTI

  1. Obtain urine culture immediately (do not wait for results to initiate treatment). 1

  2. Initiate empiric treatment with nitrofurantoin 50-100 mg four times daily for 7 days as first-line. 1

  3. Alternative options if nitrofurantoin is contraindicated:

    • Fosfomycin 3g single dose 1
    • Cephalexin 500 mg four times daily for 7-14 days 1
    • Amoxicillin-clavulanate if pathogen is susceptible 1
  4. Adjust therapy based on culture results and susceptibility testing. 1

  5. Obtain follow-up urine culture 1-2 weeks post-treatment to confirm cure. 1

References

Guideline

Treatment of UTI During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nitrofurantoin and Promethazine Use in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Asymptomatic Bacteriuria in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.